Press Releases

60% of the French Population Feel Uninformed About Cancer Treatment Options According to the New Accuray / IFOP Survey SUNNYVALE, Calif., January 28, 2015 - Accuray Incorporated (Nasdaq: ARAY) announced results of a survey of 1,000 French consumers which reveal that while respondents have a basic level of knowledge on cancer care options, 60 percent believe they do not have enough information to have a personal opinion on treatments.1 Overall, the survey indicates more education may be needed to enable people to make an informed decision if faced with a cancer diagnosis. Read More »
Accuray Reports Financial Results for Second Quarter of Fiscal Year 2015 SUNNYVALE, Calif., January 27, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2014. Read More »
Accuray to Report Results for Second Quarter Fiscal 2015 on January 27, 2015 SUNNYVALE, CALIF., January 12, 2015—Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2014 on January 27, 2015 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. Read More »
Centre Hospitalier Regional Universitaire (CHRU) in Tours Now Treating Patients with the TomoTherapy® System SUNNYVALE, Calif., January 9, 2015 – Accuray Incorporated (Nasdaq: ARAY) announced today that CHRU Tours is now treating cancer patients with the TomoTherapy® System. Read More »
Accuray to Present at JP Morgan 33rd Annual Healthcare Conference SUNNYVALE, Calif., December 16, 2014 – Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the JP Morgan 33rd Annual Healthcare Conference in San Francisco on Monday, January 12, 2015 at 4:00 p.m. PST/7:00 p.m. EST. Read More »
First CyberKnife® Full-Body Radiosurgery System in Manhattan Now Treating Patients SUNNYVALE, Calif., November 18, 2014 – Accuray Incorporated (Nasdaq: ARAY) announced today that the first CyberKnife® System in Manhattan is now treating patients at Winthrop University Hospital’s NYCyberKnife Center. Winthrop’s decision to install the latest generation CyberKnife M6™ System reinforces its growing reputation as a dedicated radiosurgery device that delivers extremely precise full-body treatments while maximizing patients' quality of life during and after treatment. Read More »
Accuray to Participate in Brean Capital’s 2014 Life Science Conference SUNNYVALE, Calif., November 10, 2014 – Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to participate in the Brean Capital 2014 Life Science Conference in New York City on Monday, November 24, 2014. Read More »
Studies Support the Use of the CyberKnife® System as a Safe and Effective Option to Treat Neurological Diseases SUNNYVALE, Calif., November 3, 2014 -- Accuray Incorporated (Nasdaq: ARAY) announced that studies presented at the 15th European Congress of Neurosurgical Societies (EANS) in Prague, October 12 – 17, 2014 reinforce the benefits of the CyberKnife® Robotic Radiosurgery System for the treatment of neurological diseases such as meningiomas, acoustic neuromas, trigeminal neuralgia, and spinal tumors. Read More »

Pages